Absci Corp (ABSI)

Currency in USD
7.550
+0.075(+1.00%)
Real-time Data·
ABSI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.3407.790
52 wk Range
2.24012.545
Key Statistics
Prev. Close
7.475
Open
7.57
Day's Range
7.34-7.79
52 wk Range
2.24-12.545
Volume
2.97M
Average Volume (3m)
3.93M
1-Year Change
164.3357%
Book Value / Share
1.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABSI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.091
Upside
+99.88%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Absci Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15.091
(+99.88% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Buy14.00+85.80%15.00MaintainNov 16, 2026
Truist Securities
Buy17.00+125.61%-MaintainNov 09, 2026
Jefferies
Buy14.00+85.80%-New CoverageOct 29, 2026
H.C. Wainwright
Buy16.00+112.34%-MaintainOct 20, 2026
KeyBanc
Buy20.00+165.43%16.00MaintainOct 16, 2026

Absci Corp Earnings Call Summary for Q3/2026

  • Absci posted Q3 2026 revenue of $304K, missing estimates of $697.6K by 56.4%; adjusted loss of $0.19/share met expectations; shares fell 7.26%.
  • R&D spending rose 23% YoY to $23.6M to advance ABS-201; cash reserves of $173.7M expected to fund operations into second half of 2028.
  • Company expects 13-week proof-of-concept data for ABS-201 in pattern hair loss in December 2026, full 26-week data in early 2027.
  • Phase II STORYLINE trial in endometriosis planned for mid-2027, pending protocol finalization and regulatory clearance.
  • Management pursuing direct-to-consumer strategy for ABS-201, aiming to create 'new premium category' in pattern hair loss therapy market.
Last Updated: 12/11/2026, 15:58
Read Full Transcript

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
-0.19 / -0.19
Revenue / Forecast
304K / 697.57K
EPS Revisions
Last 90 days

ABSI Income Statement

Compare ABSI to Peers and Sector

Metrics to compare
ABSI
Peers
Sector
Relationship
P/E Ratio
−10.4x−2.7x−0.2x
PEG Ratio
−0.90−0.070.00
Price/Book
6.0x2.5x2.6x
Price / LTM Sales
878.8x72.0x2.7x
Upside (Analyst Target)
101.1%111.9%66.0%
Fair Value Upside
Unlock2.9%10.8%Unlock

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
66.13M38.53%494.33M
Other Institutional Investors
109.84M61.47%821.08M
Public Companies & Retail Investors
0.000.00%0.00
Total
175.97M100.00%1.32B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC15.00%25,742,031192,422
BlackRock, Inc.7.81%13,396,310100,137

People Also Watch

547.21
LITE
+0.22%
63.11
TEM
-2.55%
206.66
COHR
+1.59%
11.000
ABCL
-1.08%

FAQ

What Is the Absci (ABSI) Stock Price Today?

The Absci stock price today is 7.550 USD.

What Stock Exchange Does Absci Trade On?

Absci is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Absci?

The stock symbol for Absci is "ABSI."

What Is the Absci (ABSI) Afterhours Price Today? (Afterhours variable test: 7.600) Current Date: Nov 17, 2026

After hours price: 7.600. After hours price change (units): 0.125. Price change percentage: 1.670%

What Is the Absci Market Cap?

As of today, Absci market cap is 1.310B USD.

What Is Absci's Earnings Per Share (TTM)?

The Absci EPS (TTM) is -0.79.

When Is the Next Absci Earnings Date?

Absci will release its next earnings report on Mar 23, 2027.

From a Technical Analysis Perspective, Is ABSI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Absci Stock Split?

Absci has split 0 times.

How Many Employees Does Absci Have?

Absci has 140 employees.

What is the current trading status of Absci (ABSI)?

As of Nov 17, 2026, Absci (ABSI) is trading at a price of 7.550 USD, with a previous close of 7.475 USD. The stock has fluctuated within a day range of 7.340 USD to 7.790 USD, while its 52-week range spans from 2.240 USD to 12.545 USD.

What Is Absci (ABSI) Price Target According to Analysts?

The average 12-month price target for Absci is 15.091 USD, with a high estimate of 20 USD and a low estimate of 10 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +99.88% Upside potential.

What Is the ABSI Premarket Price?

ABSI's last pre-market stock price is 7.716 USD. The pre-market share volume is 39,690.000, and the stock has decreased by 0.241, or 3.220%.

What Is the ABSI After Hours Price?

ABSI's last after hours stock price is 7.600 USD, the stock has decreased by 0.125, or 1.670%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.